Reconnecting

The current page stays visible while onset.to reconnects in the background.

Connection error

onset.to could not restore the live connection within 5 seconds. Reload the page to recover.

Log in

DXM

DXM content spanning pharmacology, plateau dosing, harm reduction, and community discussion around dextromethorphan as a dissociative substance.

Most recent Latest added

Most recent Latest added

4 entries

March 29, 2026

A Flawed Blockbuster and Its Challengers: clinic economics will decide psilocybin’s fate

darkmatterpragmatism.substack.com · Mar 29, 2026 · Adam D. Borecky, MD

Psilocybin Ketamine Article Business +3

February 6, 2026

Generation Dissociation: How ketamine and other dissociative substances relate to trauma, relief, and harm reduction

firesideproject.org · Feb 6, 2026 · James Stephen

Ibogaine Ketamine Article HarmReduction +5

October 16, 2025

Psychedelic Funding Update: Q3 2025 - Tracker highlights $120M raised across eight financing events and key rounds from major companies

psychedelicalpha.com · Oct 16, 2025

LSD Psilocybin Article Business +9

June 6, 2025

Bad trips can lead to growth in some psychedelic contexts, with LSD, psilocybin and other drugs sometimes triggering long lasting challenging experiences

salon.com · Jun 6, 2025 · Elizabeth Hlavinka

LSD Psilocybin Article Integration +10